The effect of the COVID-19 pandemic on opioid prescribing for patients with pleuritic pain.
J Opioid Manag
; 18(6): 529-535, 2022.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2202523
ABSTRACT
OBJECTIVE:
We sought to understand opioid prescribing for COVID-19 positive and negative patients with pleuritic pain during the first wave of the pandemic. We hypothesized that patients without COVID-19 would be prescribed opioids more frequently intrapandemic compared to prepandemic and postulated that COVID-19 patients would be prescribed opioids more frequently and at greater quantity than their peers.DESIGN:
A retrospective observational analysis of electronic health record data.SETTING:
A quaternary academic hospital from February through April 2020.PARTICIPANTS:
A total of 1,400 of 3,169 adult inpatient hospitalizations involving pleuritic pain were included. MAINMEASURES:
Frequency and average daily dose of opioid prescriptions were analyzed using logistic and linear regression. Opioid prescribing habits were compared pre- and intrapandemic. Hypotheses and primary outcome measures were formulated prior to data collection. KEYRESULTS:
During the pandemic, COVID-19 patients were 15.77 absolute percentage points less likely to be prescribed opioids compared to patients without COVID-19 (95 percent confidence interval (CI) -8.98 to -22.56 percent). Patients without COVID-19 were equally likely to be prescribed opioids pre- and intrapandemic (95 percent CI -9.37 to 2.42 percent). Odds ratio of opioid prescription for COVID-19 patients was 0.44 (95 percent CI 0.08-0.80). Within those given opioids, COVID-19 patients were prescribed 3.0 percent greater morphine milligram equivalents (MMEs) (95 percent CI 1.07-5.85 percent).CONCLUSION:
During the first wave of the pandemic, COVID-19 patients with pleuritic pain were prescribed opioids less frequently than patients without COVID-19, while patients without COVID-19 were equally likely to be prescribed opioid pre- and intrapandemic. On the other hand, COVID-19 patients treated with opioids were given greater daily MMEs due to the greater utilization of opioid infusions.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
/
Analgésicos Opioides
Tipo de estudio:
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Adulto
/
Humanos
Idioma:
Inglés
Revista:
J Opioid Manag
Asunto de la revista:
Neurología
/
Psicofisiología
/
Terapia por drogas
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS